izvor podataka: crosbi
!
Second line treatment for heliobacter pylori infection: Moxifloxacin based triple therapy vs sequential therapy: P1379 H. pylori (CROSBI ID 276935)
Prilog u časopisu | ostalo | međunarodna recenzija
Bago, Josip ; Halle, Željka ; Bakula, Vinko ; Perić, Rosana ; Marusic, Marinko ; Luetic, Kresimir ; Jurcic, Dragan ; Bilic, Ante ; Dominkovic, Anto
Second line treatment for heliobacter pylori infection: Moxifloxacin based triple therapy vs sequential therapy: P1379 H. pylori // Journal of gastroenterology and hepatology, 28 (2013), 545-546
Podaci o odgovornosti
Bago, Josip ; Halle, Željka ; Bakula, Vinko ; Perić, Rosana ; Marusic, Marinko ; Luetic, Kresimir ; Jurcic, Dragan ; Bilic, Ante ; Dominkovic, Anto
engleski
Second line treatment for heliobacter pylori infection: Moxifloxacin based triple therapy vs sequential therapy: P1379 H. pylori
The efficacy of moxifloxacin based triple therapy vs sequential therapy as a second line treatment is presented in this work.
Helicobacter pylori, moxifloxacin, sequential therapy
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
Povezanost rada
Povezane osobe
Povezane ustanove
